Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Important end-of-year approval by FDA: Celebrex for arthritis

Jan. 4, 1999

New COX-2 inhibitor series patented by Searle

Jan. 4, 1999

Gene transfer of plasmid DNA encoding TGF-beta for suppressing inflammation in arthritis

Dec. 30, 1998

SmithKline Beecham announces setback in RA trials

Dec. 30, 1998

Cytokine production inhibitors for inflammatory disorders in development at Ortho-McNeil

Dec. 30, 1998

Synvisc cleared for marketing in several Pacific Rim countries

Dec. 29, 1998

Phase II trial results for Immune Response's therapeutic RA vaccine published

Dec. 29, 1998

Combination of PGE1 + rolipram or pentoxifylline shows potential for RA

Dec. 28, 1998

Humanized anti-IL-6 antibody shows good efficacy and safety as rheumatoid arthritis Rx

Dec. 28, 1998

Oral human immunoglobulin proves to be safe and effective treatment for RA

Dec. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...